Trial Profile
A Randomized, Double-blind, Placebo-controlled, 12-week Treatment Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs ACT 774312 (Primary) ; Mometasone
- Indications Nasal polyps
- Focus Therapeutic Use
- Sponsors Idorsia Pharmaceuticals
- 06 Dec 2020 Status changed from active, no longer recruiting to completed.
- 22 Sep 2020 Status changed from recruiting to active, no longer recruiting.
- 24 Jul 2020 Status changed from active, no longer recruiting to recruiting.